Pulling SEC filings + quote and writing the call…

BED BATH & BEYOND, INC.
Next earnings Jul 27, 2026 (after close) · consensus $-0.33 EPS, $371M rev
Last earnings -4.8% on 2026-04-27
Revenue in freefall (-25% YoY, halved in 4 years) with persistent losses and cash burn — a cash cushion, not a business, holds it up.
Revenue $1.04B · FY2025
This is Beyond, Inc. wearing the resurrected Bed Bath & Beyond name (renamed from BYON in August 2025, per the MD&A) — an asset-light e-commerce roll-up of Bed Bath & Beyond, Overstock and buybuy BABY. The defining fact is a collapsing top line: revenue has fallen from $2.76B in FY2021 to $1.04B in FY2025, down 25.1% year-over-year, with no sign the bleeding has stopped. A shrinking-revenue retailer is the hardest kind to own, and the MD&A's own competitive framing explains why — the company concedes it fights Amazon, Walmart, Target, Wayfair, Temu and dozens more in a market where 'barriers to entry can be minimal' and shoppers increasingly start at marketplaces where BBBY 'may not be able to place' its products. An asset-light, direct-ship model in a commodity home-goods category offers little pricing power, and it shows in a 24.7% gross margin and a -5.9% operating margin.
The bull's counter is that losses are narrowing — net loss improved 67% to -$84.6M and operating loss to -$61.2M — and the balance sheet is genuinely un-stressed: $175M cash, liabilities/equity of just 0.95x, minimal long-term debt, and $218M of equity against a $402M market cap. But narrowing losses on collapsing revenue is not a turnaround; it's a controlled shrink. The company still burned $56.7M of operating cash this year and has funded that partly by issuing stock — shares outstanding rose 29.9%, diluting holders while the accumulated deficit deepened to -$843M. ROE is -38.9%. You are paying ~1.85x book for a business that destroys equity every year.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 1:00 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.76B | $1.93B | $1.56B | $1.39B | $1.04B |
| Gross profit | $624M | $508M | $366M | $290M | $258M |
| Operating income | $111M | $27.0M | -$144M | -$184M | -$61.2M |
| Net income | $389M | -$35.2M | -$308M | -$259M | -$84.6M |
| Diluted EPS | $8.11 | -$0.83 | -$6.81 | -$5.56 | -$1.41 |
| Net margin | 14.1% | -1.8% | -19.7% | -18.6% | -8.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Closed acquisition, signed material deal, issued new shares — dilutive equity financing
Entered a new material definitive agreement
Executive/board change: officer or director appointment or departure
Annual meeting: director votes, charter/bylaw amendments, officer change
Amended prior 8-K to add acquisition financial statements
Q1 10-Q: sales down ~25% YoY, still unprofitable though loss narrowing
Q1 10-Q: sales down ~25% YoY, still unprofitable though loss narrowing
Completed an acquisition/disposition plus other corporate event
Annual proxy: board slate, executive pay, and merger-related votes
Sources: SEC EDGAR (CIK 0001130713, latest 10-Q filed 2026-04-27) · EODHD · Proprietary analysis · as of 7/3/2026, 5:00:35 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-04 | Burkey Joanna M. Director | Sell | 9.94K @ $6.38 | $63.4K |
| 2026-05-15 | Corbus Barclay Director | Exercise | 26.9K | |
| 2026-05-15 | Nettles William Benjamin JR Director | Exercise | 26.9K | |
| 2026-05-15 | Shapiro Robert Jacob Director | Exercise | 26.9K | |
| 2026-05-15 | Burkey Joanna M. Director | Exercise | 26.9K | |
| 2026-05-15 | Perelman Debra Golding Director | Exercise | 26.9K | |
| 2026-05-14 | Putnam Leah R Frmr. Chief Accounting Officer | Exercise | 1.19K | |
| 2026-05-14 | Putnam Leah R Frmr. Chief Accounting Officer | Tax | 289.00 @ $4.69 | $1.36K |
| 2026-05-14 | Putnam Leah R Frmr. Chief Accounting Officer | Exercise | 11.6K | |
| 2026-05-14 | Putnam Leah R Frmr. Chief Accounting Officer | Tax | 2.83K @ $4.69 | $13.3K |
| 2026-05-14 | Putnam Leah R Frmr. Chief Accounting Officer | Exercise | 3.86K | |
| 2026-05-14 | Putnam Leah R Frmr. Chief Accounting Officer | Tax | 940.00 @ $4.69 | $4.41K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.